Philippe Arnaud

1.4k total citations
40 papers, 1.0k citations indexed

About

Philippe Arnaud is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Philippe Arnaud has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Philippe Arnaud's work include Protein purification and stability (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Philippe Arnaud is often cited by papers focused on Protein purification and stability (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Glycosylation and Glycoproteins Research (4 papers). Philippe Arnaud collaborates with scholars based in France, United States and Hungary. Philippe Arnaud's co-authors include David L. Emerson, C. Lindsay DeVane, David W. Boulton, Robert M. Galbraith, Olivier Héquet, Bertrand Coiffier, Elisabetta Gianazza, Gèrard Socié, Gilles Salles and Catherine Thiéblemont and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Philippe Arnaud

37 papers receiving 1.0k citations

Peers

Philippe Arnaud

PFM

ONCOL

EPIDE

HEMAT

Chantal Le Guellec France

P. Deteix France

Joseph Bubalo United States

Chang‐Fang Chiu Taiwan

H A Capell United Kingdom

Venkatraman Radhakrishnan India

Fikret Arpacı Türkiye

Piero Stratta Italy

Wei-Shu Wang Taiwan

John McCormick United States

Chantal Le Guellec France

Philippe Arnaud

132 ×0.6

PFM

286 ×1.4

ONCOL

156 ×0.9

EPIDE

213 ×1.2

78 ×0.5

HEMAT

Citations per year, relative to Philippe Arnaud Philippe Arnaud (= 1×) peers Chantal Le Guellec

Countries citing papers authored by Philippe Arnaud

Since Specialization

Citations

This map shows the geographic impact of Philippe Arnaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Arnaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Arnaud more than expected).

Fields of papers citing papers by Philippe Arnaud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Arnaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Arnaud. The network helps show where Philippe Arnaud may publish in the future.

Co-authorship network of co-authors of Philippe Arnaud

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Arnaud. A scholar is included among the top collaborators of Philippe Arnaud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Arnaud. Philippe Arnaud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Victorri‐Vigneau, Caroline, C. Collin, Michel Mallaret, et al.. (2014). Designing a tool allowing for a standardized assessment of resistance to drug diversion. Expert Opinion on Drug Delivery. 11(7). 995–1004. 3 indexed citations

Curis, Emmanuel, Naïma Zerrouk, N. Neveux, et al.. (2011). Endotoxemia affects citrulline, arginine and glutamine bioavailability. European Journal of Clinical Investigation. 42(3). 282–289. 28 indexed citations

Béreau, Virginie, Véronique Jubera, Philippe Arnaud, et al.. (2010). Modulation of the luminescence quantum efficiency for blue luminophor {Al(salophen)}+ by ester-substituents. Dalton Transactions. 39(8). 2070–2070. 37 indexed citations

Lidove, Olivier, et al.. (2009). Enzyme therapy in Fabry disease: severe adverse events associated with anti‐agalsidase cross‐reactive IgG antibodies. British Journal of Clinical Pharmacology. 68(5). 765–769. 25 indexed citations

Skiba, Mohamed, et al.. (2009). Sinefungin-PLGA Nanoparticles: Drug Loading, Characterization, <I>In Vitro</I> Drug Release and <I>In Vivo</I> Studies. Journal of Nanoscience and Nanotechnology. 9(1). 150–158. 11 indexed citations

Arnaud, Philippe. (2006). Chevagnes. ADLFI Archéologie de la France - Informations. 1 indexed citations

Meunier, Jérôme, Livia Lumbroso‐Le Rouic, R. Dendale, et al.. (2006). Conjunctival low-grade non-Hodgkin's lymphoma: a large single-center study of initial characteristics, natural history and prognostic factors. Leukemia & lymphoma. 47(7). 1295–1305. 20 indexed citations

Thomas, Xavier, Mohamed Elhamri, Youcef Chelghoum, et al.. (2005). Intensive chemotherapy with mitoxantrone administered as a single injection in patients with high-risk acute myeloid leukemia: results of the EMA 2000 trial. Annals of Hematology. 84(6). 376–382. 7 indexed citations

Arnaud, Philippe, et al.. (2004). U shape prestressed concrete decks for LRT / MRT viaducts. 66–67. 4 indexed citations

10.

Lemieux, Bernard, Fadhela Bouafia, Catherine Thiéblemont, et al.. (2004). Second treatment with rituximab in B-cell non-Hodgkin's lymphoma: efficacy and toxicity on 41 patients treated at CHU-Lyon Sud. The Hematology Journal. 5(6). 467–471. 18 indexed citations

11.

Marchais, H., et al.. (2003). Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release. European Journal of Pharmaceutical Sciences. 19(2-3). 129–132. 21 indexed citations

12.

Thiéblemont, Catherine, Charles Dumontet, Fadhela Bouafia, et al.. (2002). Outcome in Relation to Treatment Modalities in 48 Patients with Localized Gastric MALT Lymphoma: A Retrospective Study of Patients Treated During 1976-2001. Leukemia & lymphoma. 44(2). 257–262. 29 indexed citations

13.

Lundqvist, Mats L., Holly A. Gefroh, Philippe Arnaud, et al.. (2002). Cloning of the IgM heavy chain of the bottlenose dolphin (Tursiops truncatus), and initial analysis of VH gene usage. Developmental & Comparative Immunology. 26(6). 551–562. 11 indexed citations

14.

Kalabay, László, L Jakab, Zoltán Prohászka, et al.. (2002). Human fetuin/α2HS-glycoprotein level as a novel indicator of liver cell function and short-term mortality in patients with liver cirrhosis and liver cancer. European Journal of Gastroenterology & Hepatology. 14(4). 389–394. 64 indexed citations

15.

Atchley, Daniel H., C. Anne Morrison, Seetal Dodd, et al.. (2002). One step purification of alpha1-acid glycoprotein from human plasma. Journal of Chromatography B. 784(1). 33–38. 8 indexed citations

16.

Thiéblemont, Catherine, Pascale Felman, Françoise Berger, et al.. (2002). Treatment of Splenic Marginal Zone B-Cell Lymphoma: An Analysis of 81 Patients. Clinical Lymphoma. 3(1). 41–47. 112 indexed citations

17.

McCollam, Patrick L., Michael A. Crouch, & Philippe Arnaud. (1998). Caucasian versus African‐American Differences in Orosomucoid: Potential Implications for Therapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 18(3). 620–626. 9 indexed citations

18.

Petrini, Mario, et al.. (1993). Is binding of vitamin D binding protein related to cell differentiation?. Leukemia Research. 17(7). 561–565. 3 indexed citations

19.

Gianazza, Elisabetta, et al.. (1988). The use of dye-ligand affinity chromatography for the purification of non-enzymatic human plasma proteins. Journal of Biochemical and Biophysical Methods. 16(1). 1–15. 15 indexed citations

20.

Johnson, Elizabeth L., et al.. (1987). Purification of IgM monoclonal antibody from murine ascitic fluid by a two-step column chromatography procedure. Immunology Letters. 14(2). 159–165. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact